Skip to main content
OpenTrials
Completed

NCT Number: NCT04785404

Primary Versus Secondary Closure of Stoma-Reversal Skin Wound

to compare infection rate stoma reversal skin wound after primary or secondary closure

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ayub teaching hospital

Abbottābād, Khyber Pakhtunkhwa, 22040, Pakistan

About this study

There will be two groups. In group A, skin will be stitched with prolene while in group B skin will be left open to follow up till 1 month and wound observed for infection according to CDC guidelines.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • . All patients who undergo ileostomy or colostomy reversal will be included

Exclusion criteria

  • included patients with reversal of stoma through laparatomy, post-operative anastomotic leak and co-morbidities like diabetes, Chronic liver disease, chronic kidney disease etc

Treatment and study plan

primary skin closure

Procedure

skin will be stitched after stoma reversal to heal by primary intention

Primary outcomes

  1. surgical site infection

    Time frame: 30 days

    skin wound infection at surgical site will be observed on CDC guidelines

Sponsors and collaborators

Lead sponsor

Ayub Teaching Hospital

Other

Registry information

Official study title

Primary Versus Secondary Closure of Stoma-Reversal Skin Wound: Randomized Controlled Trial

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Mar 5, 2021
Registry last updated
Jul 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.